Bifogade filer
Kurs
-5,38%
Kurs
-5,38%
Open
17,75
High
17,75
Low
16,49
Close
16,79
Kursutveckling under dagen för detta pressmeddelande
(EUR).
Kalender
Est. tid* | ||
2025-07-31 | - | Kvartalsrapport 2025-Q2 |
2025-05-16 | - | X-dag ordinarie utdelning CRBN 0.64 EUR |
2025-05-14 | - | Årsstämma |
2025-02-27 | - | Bokslutskommuniké 2024 |
2024-08-08 | - | Kvartalsrapport 2024-Q2 |
2024-05-17 | - | X-dag ordinarie utdelning CRBN 0.61 EUR |
2024-05-15 | - | Årsstämma |
2024-05-02 | - | X-dag bonusutdelning CRBN 0.1 |
2024-03-01 | - | Bokslutskommuniké 2023 |
2023-08-10 | - | Kvartalsrapport 2023-Q2 |
2023-05-19 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
2023-05-17 | - | Årsstämma |
2023-03-03 | - | Bokslutskommuniké 2022 |
2022-08-10 | - | Kvartalsrapport 2022-Q2 |
2022-07-05 | - | Extra Bolagsstämma |
2022-05-20 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
2022-05-18 | - | Årsstämma |
2022-02-25 | - | Bokslutskommuniké 2021 |
2021-10-27 | - | Kvartalsrapport 2021-Q3 |
2021-07-20 | - | Kvartalsrapport 2021-Q2 |
2021-05-21 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
2021-05-19 | - | Årsstämma |
2021-04-30 | - | Kvartalsrapport 2021-Q1 |
2021-03-05 | - | Bokslutskommuniké 2020 |
2020-10-12 | - | Kvartalsrapport 2020-Q3 |
2020-07-17 | - | Kvartalsrapport 2020-Q2 |
2020-07-01 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
2020-06-29 | - | Årsstämma |
2020-04-30 | - | Kvartalsrapport 2020-Q1 |
2020-01-13 | - | Bokslutskommuniké 2019 |
2019-11-01 | - | Kvartalsrapport 2019-Q3 |
2019-08-07 | - | Kvartalsrapport 2019-Q2 |
2019-08-05 | - | Extra Bolagsstämma |
2019-04-26 | - | Kvartalsrapport 2019-Q1 |
2025-07-31 07:00:00
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its half-year 2025 results ending 30 June 2025.
Key highlights half-year results 2025:
- Organic sales growth: +2.9% | (Q2: -1.6%) | |
- Volume/mix: +3.3% | (Q2: -1.3%) | |
- Price: -0.4% | (Q2: -0.3%) | |
- Sales € 645.6 million | (Q2: € 315.9 million) | |
- Adjusted EBITDA: € 106.6 million | (Q2: € 52.2 million) | |
- Adjusted EBITDA organic growth +29.3% | ||
- Adjusted EBITDA margins improved +300 bps to 16.5% | ||
- Operating profit € 63.5 million | ||
- Volume/mix growth in both business segments | ||
- Cash flow from operating activities € 45.7 million, Free Cash Flow € 12.1 million | ||
- FY 2025 outlook maintained | ||
€ million | H1 2025 | H1 2024 | H1 growth | H1 Organic growth | Q2 2025 | Q2 2024 | Q2 growth | Q2 Organic growth | |||||
Sales | 645.6 | 637.1 | +1.3% | +2.9% | 315.9 | 336.7 | -6.2% | -1.6% | |||||
Adjusted EBITDA | 106.6 | 86.1 | +23.8% | +29.3% | 52.2 | 51.6 | +1.2% | +12.8% | |||||
Adj. EBITDA margin | 16.5% | 13.5% | 16.5% | 15.3% | |||||||||
Operating profit | 63.5 | 33.6 | +89.0% | +100.3% | 29.5 | 22.0 | +34.1% | +55.0% | |||||